Envoy Medical, Inc.
COCH
Positions held
Your positionsCOCH isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $50.76M | Enterprise value | $31.89M | Trailing P/E | — | Forward P/E | -2.78 |
| PEG | — | Price / book | 13.70 | Beta | 1.95 | Dividend yield | 0.00% |
| Revenue growth | -34.6% | Earnings growth | — | Gross margin | -2.9% | Operating margin | -109.2% |
| Profit margin | 0.0% | ROE | — | ROA | -86.5% | Debt / equity | 0.22 |
| Current ratio | 1.74 | Free cash flow | -$8.22M | Analyst recommendation | strong_buy | Mean target | $2.17 |
| 52w high | $1.02 | 52w low | $0.36 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.1M | $0.0M | $0.1M | $0.0M | $0.1M | — |
| Op margin | -10919.6% | -15279.5% | -8513.3% | -13590.5% | -6500.0% | — |
| Net income | -$6.0M | -$4.4M | -$6.6M | -$6.5M | -$5.7M | — |
| Gross margin | -445.1% | -702.6% | -181.3% | -383.3% | -200.0% | — |
| Gross profit | -$0.2M | -$0.3M | -$0.1M | -$0.2M | -$0.2M | — |
| Operating income | -$5.6M | -$6.0M | -$6.4M | -$5.7M | -$5.1M | — |
- Revenue +31% vs prior quarter ($0.1M vs $0.0M).
- Gross margin -445.1% (was -702.6% prior quarter).
- Operating margin expanded to -10919.6%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0.2M | $0.2M | $0.3M | $0.2M |
| Op margin | -9240.7% | -8558.2% | -5809.8% | -3673.4% |
| Net income | -$23.8M | -$20.8M | -$29.9M | -$15.9M |
| Gross margin | -262.7% | -229.8% | -149.7% | -110.1% |
| Gross profit | -$0.6M | -$0.5M | -$0.5M | -$0.3M |
| Operating income | -$22.3M | -$19.3M | -$18.4M | -$8.7M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-22 · Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio
2026-09-02 · Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th
2026-08-21 · Are Medical Stocks Lagging Compugen (CGEN) This Year?
2026-08-10 · Envoy Medical, Inc. (COCH) Reports Q2 Loss, Misses Revenue Estimates
2026-08-10 · Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones
2026-07-23 · Envoy Medical, Inc. (COCH) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
2026-07-21 · Envoy Medical Surpasses Three-Month Visit Milestone for All 56 Patients in Pivotal Clinical Trial
2026-07-21 · EXCLUSIVE: Envoy Medical Hits Key Clinical Trial Milestone for Fully Implanted Ear Implant
2026-07-17 · Is Humana (HUM) Stock Outpacing Its Medical Peers This Year?
2026-07-14 · EXCLUSIVE: Envoy Medical Builds Momentum With Improved Cochlear Implant Trial Results
Price (daily)
Full chart · RSI · MACD · patterns